Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands

Folgerdiena M. de Vries*, Petra Denig, Sipke T. Visser, Eelko Hak, Maarten J. Postma

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)
198 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands'. Together they form a unique fingerprint.

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases